Report for Juillerat-Jeanneret L

General

Full name :

First name :

Mail :

Zip Code :

City :

Country :

Email :

Phone :

Fax :

Website :

Directory :

References (4)

Title : Virtual screening and computational optimization for the discovery of covalent prolyl oligopeptidase inhibitors with activity in human cells - De Cesco_2012_J.Med.Chem_55_6306
Author(s) : De Cesco S , Deslandes S , Therrien E , Levan D , Cueto M , Schmidt R , Cantin LD , Mittermaier A , Juillerat-Jeanneret L , Moitessier N
Ref : Journal of Medicinal Chemistry , 55 :6306 , 2012
Abstract : De Cesco_2012_J.Med.Chem_55_6306
ESTHER : De Cesco_2012_J.Med.Chem_55_6306
PubMedSearch : De Cesco_2012_J.Med.Chem_55_6306
PubMedID: 22765237

Title : Inhibitors of prolyl oligopeptidases for the therapy of human diseases: defining diseases and inhibitors -
Author(s) : Lawandi J , Gerber-Lemaire S , Juillerat-Jeanneret L , Moitessier N
Ref : Journal of Medicinal Chemistry , 53 :3423 , 2010
PubMedID: 20058865

Title : The prolyl-aminodipeptidases and their inhibitors as therapeutic targets for fibrogenic disorders - Juillerat-Jeanneret_2009_Mini.Rev.Med.Chem_9_215
Author(s) : Juillerat-Jeanneret L , Gerber-Lemaire S
Ref : Mini Rev Med Chem , 9 :215 , 2009
Abstract : Juillerat-Jeanneret_2009_Mini.Rev.Med.Chem_9_215
ESTHER : Juillerat-Jeanneret_2009_Mini.Rev.Med.Chem_9_215
PubMedSearch : Juillerat-Jeanneret_2009_Mini.Rev.Med.Chem_9_215
PubMedID: 19200026

Title : Constrained peptidomimetics reveal detailed geometric requirements of covalent prolyl oligopeptidase inhibitors - Lawandi_2009_J.Med.Chem_52_6672
Author(s) : Lawandi J , Toumieux S , Seyer V , Campbell P , Thielges S , Juillerat-Jeanneret L , Moitessier N
Ref : Journal of Medicinal Chemistry , 52 :6672 , 2009
Abstract : Lawandi_2009_J.Med.Chem_52_6672
ESTHER : Lawandi_2009_J.Med.Chem_52_6672
PubMedSearch : Lawandi_2009_J.Med.Chem_52_6672
PubMedID: 19888757